Fig. 4

Restricted cubic spline plots of the dose-response relationship between aMED and mortality A. Dose-response relationship between aMED and all-cause mortality; B. Dose-response relationship between aMED and CVD mortality; C. Dose-response relationship between aMED and all-cause mortality in participants with or without sleep disorder; D. Dose-response relationship between aMED and CVD mortality in participants with or without sleep disorder. The model was adjusted for age, sex, race (Mexican American, non-Hispanic white, non-Hispanic black, other races), education level (below high school, high school or equivalent, college or above), marital status (married, widowed, divorced, and never married), family PIR, BMI, smoking status, total energy intake, comorbidities including diabetes mellitus, hypertension, CHF, CHD, and stroke